天辰生物-B(01779)：LP-003针对季节性过敏性鼻炎适应症的生物制品许可申请(BLA)已获国家药监局受理

智通财经08-21

智通财经APP讯，天辰生物-B(01779)发布公告，LP-003针对季节性过敏性鼻炎(季节性过敏性鼻炎)适应症的生物制品许可申请(BLA)已获中国家药品监督管理局受理。LP-003是一种具有新型序列设计的抗IgE抗体。LP-003针对性治疗过敏性疾病，包括季节性过敏性鼻炎、CSU、过敏性哮喘、CRSwNP和食物过敏。LP-003的主要功能是阻断血液和组织中的游离IgE，从而抑制IgE介导的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2661302392?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-08-21 06:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2661302392","market":"hk","top_or_hot":-1,"title":"天辰生物-B(01779)：LP-003针对季节性过敏性鼻炎适应症的生物制品许可申请(BLA)已获国家药监局受理","media":"智通财经","content":"<div>\n<p>智通财经APP讯，天辰生物-B(01779)发布公告，LP-003针对季节性过敏性鼻炎(季节性过敏性鼻炎)适应症的生物制品许可申请(BLA)已获中国家药品监督管理局受理。LP-003是一种具有新型序列设计的抗IgE抗体。LP-003针对性治疗过敏性疾病，包括季节性过敏性鼻炎、CSU、过敏性哮喘、CRSwNP和食物过敏。LP-003的主要功能是阻断血液和组织中的游离IgE，从而抑制IgE介导的...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1483003.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>天辰生物-B(01779)：LP-003针对季节性过敏性鼻炎适应症的生物制品许可申请(BLA)已获国家药监局受理</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n天辰生物-B(01779)：LP-003针对季节性过敏性鼻炎适应症的生物制品许可申请(BLA)已获国家药监局受理\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-21 06:21 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1483003.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，天辰生物-B(01779)发布公告，LP-003针对季节性过敏性鼻炎(季节性过敏性鼻炎)适应症的生物制品许可申请(BLA)已获中国家药品监督管理局受理。LP-003是一种具有新型序列设计的抗IgE抗体。LP-003针对性治疗过敏性疾病，包括季节性过敏性鼻炎、CSU、过敏性哮喘、CRSwNP和食物过敏。LP-003的主要功能是阻断血液和组织中的游离IgE，从而抑制IgE介导的...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1483003.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1483003.html","article_id":"2661302392","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2661302392","pubTimestamp":1787264506,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，天辰生物-B 发布公告，LP-003针对季节性过敏性鼻炎适应症的生物制品许可申请已获中国家药品监督管理局受理。LP-003针对性治疗过敏性疾病，包括季节性过敏性鼻炎、CSU、过敏性哮喘、CRSwNP和食物过敏。LP-003的主要功能是阻断血液和组织中的游离IgE，从而抑制IgE介导的过敏反应的发生。抗IgE疗法已被纳入中国季节性过敏性鼻炎和CSU的诊治指南。LP-003针对花生过敏适应症的IND申请亦已获美国食品药品监督管理局 批准。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1161":"生物科技","01779":"天辰生物-B"},"translate_title":"Tianchen Bio-B (01779): LP-003 Biologics License Application (BLA) for seasonal allergic rhinitis indications has been accepted by the NMPA","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01779":1.5},"content_text":"智通财经APP讯，天辰生物-B(01779)发布公告，LP-003针对季节性过敏性鼻炎(季节性过敏性鼻炎)适应症的生物制品许可申请(BLA)已获中国家药品监督管理局受理。LP-003是一种具有新型序列设计的抗IgE抗体。LP-003针对性治疗过敏性疾病，包括季节性过敏性鼻炎、CSU、过敏性哮喘、CRSwNP和食物过敏。LP-003的主要功能是阻断血液和组织中的游离IgE，从而抑制IgE介导的过敏反应的发生。 LP-003能够结合游离IgE，阻止该等游离且过量的IgE与高亲和力IgE受体FcεRI结合。IgE是介导I型超敏反应的核心机制。由不同器官中的过敏原触发的I型超敏反应引发季节性过敏性鼻炎、过敏性哮喘、CSU、食物过敏以及其他过敏性疾病。由于抗IgE抗体能够阻断过敏反应的级联过程，目前在多种过敏性疾病的治疗中发挥关键作用。抗IgE疗法已被纳入中国季节性过敏性鼻炎和CSU的诊治指南。该公司已在中国获得LP-003针对多种适应症的新药临床试验(IND)批准及╱或启动相关临床试验，包括季节性过敏性鼻炎、CSU、过敏性哮喘、CRSwNP及食物过敏。LP-003针对花生过敏适应症的IND申请亦已获美国食品药品监督管理局 (FDA)批准。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2661302392","isCrawlerRequest":true}